CLEVELAND, OH, December 03, 2025 /24-7PressRelease/ -- Peter Wilkinson has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Mr. Wilkinson currently serves as a senior solutions architect for health care and life sciences at Amazon Web Services, He is widely regarded for his rare combination of expertise in molecular biology, bioinformatics, and advanced computing. For more than two decades, he has helped transform traditional laboratories and research programs into digital, data-rich environments that support high-dimensional immunology, virology, and translational science.

In his current role, he advises pharmaceutical and life sciences organizations on securely and compliantly leveraging cloud technologies for high-performance computing, large-scale data analytics, bioinformatics and multi-omics workflows, and real-world evidence generation. He designs architectures that connect instruments, electronic laboratory notebooks, laboratory information management systems, and analytical platforms so that experimental data are captured once, preserved with full context, and made immediately available for downstream analytics, artificial intelligence, and regulatory reporting.

Alongside his industry work, Mr. Wilkinson has built a distinguished track record in academic and translational research. From 2014 to 2019, he served as a senior research associate at Case Western Reserve University, contributing to high-impact projects in immunology, vaccine mechanisms, and immune aging. His work there helped define systems-level signatures of immune activation and "inflamm-aging," and was highlighted in Science Translational Medicine for its importance in understanding age-associated changes in the immune system. From 2021 to 2022, he extended this translational focus as a senior bioinformatician at Rush University Medical Center, conducting advanced research in gut health and mucosal immunology and integrating complex laboratory data with clinical insights.

A pivotal period in Mr. Wilkinson's career occurred from 2009 to 2014, when he served as senior bioinformatician and information technology coordinator at the Vaccine and Gene Therapy Institute of Florida. There, he designed and implemented network and computational infrastructures to support cutting-edge work in HIV and viral immunology. In 2012, he orchestrated the seamless transition of the institute's laboratories to a new facility with no downtime, implementing a forward-looking cabling architecture and early cloud-based systems that anticipated modern digital laboratory practices. For these accomplishments, he received an award for excellence from VGTI Florida and earned recognition for his ability to bridge information technology, laboratory operations, and scientific data analysis.

Earlier in his career, Mr. Wilkinson helped lay the groundwork for modern bioinformatics-driven immunology in Canada and the United States. From 2006 to 2009, as a senior bioinformatician and programmer analyst at the University of Montreal, he developed computational tools and pipelines to support genomic and immunologic research, working closely with investigators on studies of HIV pathogenesis and immune responses. From 2003 to 2006, he served as a bioinformatician at the Lady Davis Institute, contributing to foundational investigations that integrated emerging high-throughput technologies with rigorous data analysis. He began his professional journey in 1999 as a bioinformatician at Concordia University, applying his combined background in biochemistry and computer applications to some of the institution's earliest large-scale genomics projects.

In addition to his academic and institutional roles, since 2019 Mr. Wilkinson has served as a senior systems analyst with Sophic Alliance Inc., providing strategic insights into complex systems integration and data analysis for clients in the health care sector. From 2020 to 2022, he also held the role of senior data scientist and director of research and development at Sober Grid, a company dedicated to supporting individuals in recovery from addiction through innovative technology. There, he led clinical studies to evaluate a mobile application designed to help individuals maintain sobriety, trained software engineers in data collection and analysis methodologies, and ensured that the platform's scientific and data foundations could withstand clinical and regulatory scrutiny.

Mr. Wilkinson's academic preparation reflects his commitment to uniting biological insight with computational rigor. He completed a Master of Science in systems biology at Case Western Reserve University; two Bachelor of Science degrees from Concordia University—one with a specialization in biochemistry and another in computer application development; and a graduate certificate in bioinformatics from the University of British Columbia. He has also pursued professional training in good clinical laboratory practice and financial conflict-of-interest management, supporting his extensive work in regulated and semi-regulated research environments.

Mr. Wilkinson has co-authored numerous peer-reviewed publications in immunology, virology, systems biology, and computational methods. His work includes widely cited studies on HIV pathogenesis, T-cell exhaustion, immune activation, vaccine responses, infectious disease, and age-related changes in the immune system, as well as contributions to international efforts to standardize and share high-parameter flow cytometry data. The research has been supported by major national and international funding agencies, including projects aligned with funding from the National Institutes of Health, Genome Canada, Genome Quebec, and Genome B.C., Bill and Melinda Gates Foundation, and other public-sector organizations.

He attributes his success to his ability to think fluently across disciplines and to communicate effectively with immunologists, clinicians, information technology professionals, data scientists, and software engineers. Colleagues frequently call upon him to design and troubleshoot complex systems and advise on what is scientifically justified, methodologically sound, and operationally responsible. His work is grounded in a commitment to reproducible research, careful documentation, and the conviction that scientific software and digital infrastructures must be as dynamic and inquisitive as the scientists and clinicians who rely on them. He applied these principles and patterns in key writing roles for projects and genomics/bioinformatics/modeling technology cores for grants and contracts applications that has funded the numerous investigators and co-authors of the aforementioned peer-reviewed publications sponsored by their respective public and private funding organizations.

Mr. Wilkinson's interest in his field began during his undergraduate studies, when he first worked with PCGene, an early simple program for gene analysis that ran on DOS systems. Inspired by the advent of gel capillary sequencing and the expanding genetic repositories at the National Center for Biotechnology Information of the National Institutes of Health, he chose a path that allowed him to develop both his passion for molecular biology and his skills in computing, networking, and systems design. As a young systems builder, he developed custom data processing tools in an era of limited resources, working on high-throughput systems based on DEC Alpha and VAX mainframes. These early experiences laid the groundwork for a career devoted to integrating biology, computation, and infrastructure.

Beyond his professional pursuits, Mr. Wilkinson has demonstrated civic engagement by coaching youth soccer teams in the United States including 20 years as an ice hockey official in Canada and the US, leading youth in outdoor summer programe and participating in other community activities. A lifelong student of science, history, and classical literature, he views his work not simply as technical problem-solving but as part of a broader, long-standing effort to improve human health and deepen our understanding of the living world.

His innovative contributions have been recognized with multiple honors, including an award from VGTI Florida for excellence during the Vaccine and Gene Therapy Institute transition project and recognition associated with national grants and consortia focused on advancing high-parameter flow cytometry, systems immunology, and multi-omics analysis. Looking ahead, Mr. Wilkinson intends to continue advancing digital laboratory and clinical infrastructures and to further develop intelligent, agent-driven systems that help scientists and clinicians ask—and answer—more ambitious questions in human biology and medicine.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.

# # #